Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Showing 31 to 34 of 34

TitleReference numberPublishedLast updated
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancerTA531
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapyTA428
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumabTA357
Pembrolizumab for advanced melanoma not previously treated with ipilimumabTA366

Results per page

  1. 10
  2. 25
  3. 50
  4. All